Favourable prognostic factors with infantile spasms

European Journal of Paediatric Neurology

Volumn 14, Issue 1, 2010, Pages 13-18

  Riikonen, Raili S ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Favourable factors; Infantile spasms; Prognosis

Indexed keywords

CORTICOTROPIN; COTRIMOXAZOLE; DIAZEPAM; HYDROCORTISONE; STEROID; VIGABATRIN;

ADRENAL DISEASE; ANTIBIOTIC PROPHYLAXIS; AUTISM; BRAIN METABOLISM; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COGNITION; DRUG DOSE COMPARISON; DRUG MEGADOSE; EEG ABNORMALITY; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; EUROPE; FINLAND; FOCAL EPILEPSY; GENE MUTATION; HERPES SIMPLEX ENCEPHALITIS; HORMONAL THERAPY; HUMAN; HYPERKINESIA; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; HYPOGLYCEMIA; HYPSARRHYTHMIA; INFANT; INFANTILE SPASM; INFECTION; INTELLIGENCE; LEARNING DISORDER; LOW DRUG DOSE; MENTAL DISEASE; MENTAL HEALTH; MORTALITY; ONSET AGE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT INFECTION; REVIEW; SMALL FOR DATE INFANT; STEROID THERAPY; THERAPY DELAY; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VISUAL FIELD; VISUAL FIELD DEFECT;

ADRENOCORTICOTROPIC HORMONE; ANTICONVULSANTS; DEVELOPMENTAL DISABILITIES; ELECTROENCEPHALOGRAPHY; HUMANS; INFANT; PROGNOSIS; SPASMS, INFANTILE; TREATMENT OUTCOME; VIGABATRIN;

EID: 71649091226     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2009.03.004     Document Type: Review

References (68)

1. ILEA Commission Report. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: a report of the ILEA task force on classification and terminology. Epilepsia 42 (2001) 796-803
2. Lux A., and Osborne J. A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia 45 (2004) 1416-1428
3. Riikonen R. Decreasing perinatal mortality: unchanged infantile spasm morbidity. Dev Med Child Neurol 37 (1995) 232-238
4. Riikonen R. Epidemiological data of West syndrome in Finland. Brain Dev 23 (2001) 539-541
5. Kato M. A new paradigm for West syndrome based on molecular and cell biology. Epilepsy Res 70 Suppl. 1 (2006) S87-S95
6. Gaily E., Liukkonen E., Paetau R., Rekola M., and Granström M.-L. Infantile spasms: diagnosis and assessment of treatment response by video-EEG. Dev Med Child Neurol 43 (2001) 658-667
7. Dulac O., Plouin P., and Jambaque I. Predicting favourable outcome in idiopathic West syndrome. Epilepsia 34 (1993) 747-756
8. Riikonen R., Söderström S., Vanhala R., Ebendal T., and Lindholm D. West syndrome: cerebrospinal fluid nerve growth factor and effect of ACTH. Pediatr Neurol 17 (1997) 224-229
9. Airaksinen E., Tuomisto L., and Riikonen R. The concentrations of GABA, 5-HIAA and HVA in the cerebrospinal fluid of children with infantile spasms and effects of ACTH treatment. Brain Dev 14 (1992) 386-390
10. Riikonen R. How do cryptogenic and symptomatic infantile spasms differ. Review of biochemical studies in Finnish patients. J Child Neurol 11 (1996) 383-388
11. Vanhatalo S., and Riikonen R. Nitric metabolites, nitrates and nitrites in the cerebrospinal fluid in children with West syndrome. Epilepsy Res 46 (2001) 3-13
12. Donat J., and Wright F. Unusual variants of infantile spasms. J Child Neurol 6 (1991) 313-316
13. Shields W. Infantile spasms: little seizures, big consequences. Epilepsy Curr 6 (2006) 63-69
14. Granström M.-L., Gaily E., and Liukkonen E. Treatment of infantile spasms: results of a population-based study with vigabatrin as the first drug for spasms. Epilepsia 40 (1999) 950-957
15. Caraballo R., Cersosimo R., Arroyo H., and Fejerman N. Symptomatic West's syndrome: specific link to unexpected response to treatment. Rev Neurol 26 (1998) 372-375
16. Nabbout R., Melki I., Gerbaka B., Dulac O., and Akatcherian C. Infantile spasms in Down syndrome: good response to a short course of vigabatrin. Epilepsia 42 (2001) 1580-1583
17. Eisermann M., DeLaRaillere A., Dellatolas G., Tozzi E., Nabbout R., Dulac O., et al. Infantile spasms in Down syndrome-effects of delayed anticonvulsive treatment. Epilepsy Res 55 (2003) 21-27
18. Cusmai R., Ricci S., Pinard J., Plouin P., Fariello G., and Dulac O. West syndrome due to perinatal insults. Epilepsia 34 (1993) 738-742
19. Riikonen R. Long-term outcome of West syndrome: a study of adults with a history of infantile spasms. Epilepsia 37 (1996) 367-372
20. Mackay M., Weiss S., Adams-Webber T., et al. Practice parameter: medical treatment of infantile spasms. Report of the American Academy of Neurology and Child Neurology Society. Neurology 62 (2004) 1668-1681
21. Lux A., Edwards S., Hancock E., et al. The United Kingdom infantile spasm study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomized controlled trial. Lancet 364 (2004) 1773-1778
22. Hancock E., and Osborne J. The treatment of infantile spasms (Cochrane review). The Cochrane Library, Issue 2 (2004), John Wiley and Sons, Chichester, UK
23. Vigevano P., and Cilio M. Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia 38 (1997) 1270-1274
24. Elterman R., Shields W., Mansfield K., Nakagawa J., and the US Infantile Spasms Vigabatrin Group. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 57 (2001) 1416-1421
25. Aicardi J., Sabril I.S., Investigator and peer review groups, Mumford J., Dumas C., and Wood S. Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Epilepsia 37 (1999) 637-642
26. Appleton R., Peters A., Mumford J., and Shaw D. Randomized, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia 40 (1999) 1627-1633
27. Wohlrab G., Bolthauser E., and Schmitt B. Vigabatrin as a first-line drug in West syndrome: clinical and electroencephalographic outcome. Neuropediatrics 29 (1998) 133-136
28. Baram T., Michell W., Tournay A., Snead III C., Hanson R.A., and Horton E.J. High-dose corticotrophin therapy for infantile spasms. J Pediatr 124 (1994) 803-806
29. Lombroso C. A prospective study of infantile spasms: clinical and therapeutic correlates. Epilepsia 24 (1983) 135-158
30. Riikonen R. ACTH therapy of West syndrome: Finnish views. Brain Dev 23 (2001) 642-646
31. Hrachovy R., Frost J., and Glaze D. High-dose, long-duration versus low-dose, short-duration corticotrophin therapy for infantile spasms. J Pediatr 124 (1994) 803-806
32. Nabbout R., Chiron C., Mumford J., Dumas C., Mumford J., Dumas C., and Dulac O. Vigabatrin in partial seizures in children. J Child Neurol 12 (1997) 172-177
33. Lux A., Edwards S., Hancock E., et al. United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes at age 14 months: a multicentre randomised trial. Lancet Neurol 4 (2005) 712-717
34. Riikonen R., and Donner M. ACTH therapy of infantile spasms: side effects. Arch Dis Child Neurol 55 (1980) 664-672
35. Heiskala H., Riikonen R., Santavuori P., Simell O., Airaksinen E., Nuutila A., et al. West syndrome: individualized ACTH therapy. Brain Dev 18 (1996) 456-460
36. Gross-Tsur V., Banin E., Shahar E., Shalev R., and Lahat E. Visual impairment in children with epilepsy treated with vigabatrin. Ann Neurol 48 (2000) 60-64
37. Iannetti P., Spalice A., Perla F., Conicella E., Raucci U., and Bizzarri B. Visual field constriction in children with epilepsy on vigabatrin treatment. Pediatrics 106 (2000) 838-842
38. Luchetti A., Amadi A., Gobbi G., and Bertani G. Visual field defects associated with vigabatrin therapy in children. J Neurol Neurosurg Psychiatry 69 (2000) 556 Letter
39. Vanhatalo S., Nousiainen I., Eriksson K., et al. Visual field constriction in 91 Finnish children treated with vigabatrin. Epilepsia 43 (2002) 748-756
40. Russell-Eggit I., Mackey D., Taylor D., Timms C., and Walker J. Vigabatrin-associated visual field defects in children. Eye 14 (2000) 334-339
41. Wohlrab G., Bolthauser E., Schmitt B., Schriever S., and Landau K. Visual field constriction is not limited to children treated with vigabatrin. Neuropediatrics 30 (1999) 130-132
42. Wild J., Ahn H.-s., Baulac M., et al. Vigabatrin and epilepsy: lessons learned. Epilepsia 48 (2007) 1318-1327
43. Sills G., Butler E., Forrest G., Ranaraj N., Patsalos P., and Brodie M. Vigabatrin, but not gabapentin or topiramate, produces concentration-related effects on enzymes and intermediates of the GABA shunt in rat brain and retina. Epilepsia 44 (2003) 886-892
44. Hammoudi D., Lee S., Madison A., et al. Reduced visual function associated with infantile spasms in children on vigabatrin therapy. Invest Opthalmol Vis Sci 46 (2005) 514-520
45. Nousiainen I., Kälviäinen R., and Mäntyjärvi M. Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared to healthy volunteers. Br J Opthalmol 84 (2000) 622-625
46. Ovation Pharmacoceuticals, Inc. Data on file. Vigabatrin-induced retinal dysfunction; 2007.
47. University of Toronto (2007) Data on file. Hospital for Sick Children, Toronto, Ontario.
48. Bittigau P., Sifringer R., and Ikonomidu C. Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci 993 (2003) 103-114
49. Pearl P., Louis G., Saneto R., et al. Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia 50 (2009) 184-194
50. Riikonen R. Long-term outcome of patients with West syndrome. Brain Dev 23 (2001) 683-687
51. Gaily E., Appelqvist K., Kantola-Sorsa E., et al. Cognitive deficits after cryptogenic infantile spasms. Dev Med Child Neurol 41 (1999) 660-664
52. Riikonen R., and Amnell G. Psychiatric disorders in children with earlier infantile spasms. Dev Med Child Neurol 23 (1981) 747-760
53. Chugani H., Da Silva E., and Chugani D. Infantile spasms: III. Prognostic implications of bitemporal hypometabolism on positron emission tomography. Ann Neurol 39 (1996) 643-649
54. DeLong G., and Heinz E. The clinical syndrome of early-life bilateral hippocampal sclerosis. Ann Neurol 42 (1997) 11-17
55. Curatolo P., Porfirio M., Manzi B., et al. Autism in tuberous sclerosis. Eur J Pediatr Neurol 8 (2004) 327-332
56. Riikonen R. Infantile spasms: infectious diseases. Neuropediatrics 24 (1993) 274-280
57. Riikonen R., and Simell O. Tuberous sclerosis and infantile spasms. Dev Med Child Neurol 32 (1990) 203-209
58. Jeavons P., Bower B., and Dimitracoudi M. Long-term prognosis of 150 cases of West syndrome. Epilepsia 14 (1973) 153-164
59. Koo B., Hwang P., and Logan W. Infantile spasms: outcome and prognostic factors of cryptogenic and symptomatic groups. Neurology 43 (1993) 2322-2327
60. Primec Z., Stare J., and Neubauer D. The risk of lower outcome in infantile spasms increases after three weeks of hypsarrhythmia duration. Epilepsia 47 (2006) 2202-2205
61. Kivity S., Lerman P., Ariel B., Danziger Y., Minouni M., and Shinnar S. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia 45 (2004) 255-262
62. Endoh F., Yoshinaga H., Kobayashi K., and Ohtsuka Y. Electroencephalographic changes before the onset of symptomatic West syndrome. Brain Dev 29 (2007) 630-638
63. Yoshinaga H., Endoh F., Kikumoto K., et al. Epilepsy development in infancy with epileptic discharges. Brain Dev 29 (2007) 217-223
64. Jozwiak S., Domariska-Pakiela D., Kotulska K., and Kaczorawska M. Treatment before seizures: new indications for antiepileptic therapy in children with tuberous sclerosis complex. Epilepsia 48 (2007) 1632-1634 author reply
65. Sapolsky R. Why stress is bad for your brain. Science 273 (1996) 749-750
66. Sapolsky R. Glucocorticoids, stress and exacerbation of exitoxic neuron death. Semin Neurosci 6 (1994) 323-331
67. Sachs O., and Shulman M. Steroid dementia: an overlooked diagnosis?. Neurology 64 (2005) 707-709
68. Kinironis P., Cavalleri G., Singh R., et al. A pharmacogenetic exploration of vigabatrin-induced visual field constriction. Epilepsy Res 70 (2006) 144-152